Literature DB >> 18184865

Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.

Adoración Venceslá1, María Angeles Corral-Rodríguez, Manel Baena, Mónica Cornet, Montserrat Domènech, Montserrat Baiget, Pablo Fuentes-Prior, Eduardo F Tizzano.   

Abstract

Hemophilia A (HA) is an X-linked bleeding disorder caused by a wide variety of mutations in the factor 8 (F8) gene, leading to absent or deficient factor VIII (FVIII). We analyzed the F8 gene of 267 unrelated Spanish patients with HA. After excluding patients with the common intron-1 and intron-22 inversions and large deletions, we detected 137 individuals with small mutations, 31 of which had not been reported previously. Eleven of these were nonsense, frameshift, and splicing mutations, whereas 20 were missense changes. We assessed the impact of the 20 substitutions based on currently available information about FV and FVIII structure and function relationship, including previously reported results of replacements at these and topologically equivalent positions. Although most changes are likely to cause gross structural perturbations and concomitant cofactor instability, p.Ala375Ser is predicted to affect cofactor activation. Finally, 3 further mutations (p.Pro64Arg, p.Gly494Val, and p.Asp2267Gly) appear to affect cofactor interactions with its carrier protein, von Willebrand factor, with the scavenger receptor low-density lipoprotein receptor-related protein (LRP), and/or with the substrate of the FVIIIapi*FIXa (Xase) complex, factor X. Characterization of these novel mutations is important for adequate genetic counseling in HA families, but also contributes to a better understanding of FVIII structure-function relationship.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184865      PMCID: PMC2275016          DOI: 10.1182/blood-2007-08-108068

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  80 in total

1.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.

Authors:  Ty E Adams; Matthew F Hockin; Kenneth G Mann; Stephen J Everse
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain.

Authors:  Keiji Nogami; Jan Freas; Chandrashekhara Manithody; Hironao Wakabayashi; Alireza R Rezaie; Philip J Fay
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

3.  Use of denaturing gradient gel electrophoresis to detect point mutations in the factor VIII gene.

Authors:  M D Traystman; M Higuchi; C K Kasper; S E Antonarakis; H H Kazazian
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

4.  Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution.

Authors:  D Wang; W Bode; R Huber
Journal:  J Mol Biol       Date:  1985-10-05       Impact factor: 5.469

5.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII molecule.

Authors:  M Shima; J Ware; A Yoshioka; H Fukui; C A Fulcher
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

7.  Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.

Authors:  M Higuchi; H H Kazazian; L Kasch; T C Warren; M J McGinniss; J A Phillips; C Kasper; R Janco; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).

Authors:  M Arai; H Inaba; M Higuchi; S E Antonarakis; H H Kazazian; M Fujimaki; L W Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII gene.

Authors:  J K Pattinson; D S Millar; J H McVey; C B Grundy; K Wieland; R S Mibashan; U Martinowitz; K Tan-Un; M Vidaud; M Goossens
Journal:  Blood       Date:  1990-12-01       Impact factor: 22.113

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  2 in total

1.  Prediction of hemophilia A severity using a small-input machine-learning framework.

Authors:  Tiago J S Lopes; Ricardo Rios; Tatiane Nogueira; Rodrigo F Mello
Journal:  NPJ Syst Biol Appl       Date:  2021-05-25

2.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.